Technology with a clinical purpose

Transforming patient journeys and enhancing clinician productivity for more than two decades.

Contact us

Making AI-enhanced technology more accessible.

Scribetech was founded to meaningfully improve the lives of medical professionals and patients. Today, its team delivers secure voice-driven transcription, clinical speech recognition and AI-enhanced documentation designed around how clinicians really work.

Disruptive innovation

Apply technology where it can meaningfully transform healthcare workflows.

Clinicians first

Improve the patient experience by improving the experience of clinical teams.

Continuous improvement

Keep listening, refining and responding to new needs and opportunities.

Commercial value

Deliver measurable improvement without unnecessary infrastructure upheaval.

Meet the founders

Two decades of clinical insight.
One shared purpose.

Scribetech and Augnito bring together deep NHS transcription knowledge, entrepreneurship and healthcare technology experience.

Shiraz Austin, Co-founder and Managing Director
Co-founder & Managing Director

Shiraz Austin

Shiraz has extensive knowledge of NHS transcription needs and the changing digital-data requirements of private healthcare. These clinician-first insights underpinned Augnito’s development, helping transform workflows and unlock efficiency while maintaining accuracy and precision.

Rustom Lawyer, Co-founder and CEO
Co-founder & CEO

Rustom Lawyer

Working across entrepreneurship, healthcare and technology, Rustom is focused on making voice-driven AI and ambient documentation accessible across the UK and other English-speaking markets. His aim is a more connected, digitised and interoperable healthcare system.

In depth

Everything you need to know.

01

From transcription heritage to clinical AI

Scribetech began in 2001, became the first UK company to establish outsourced transcription for the NHS, and used that operational experience to shape clinical speech technology.

  • 2005: first OJEU outsourced-transcription tender for an NHS Trust
  • 2008: ranked first for transcription services on the first NHS Framework
  • 2011–2018: AI research and development with clinicians and academic experts
  • 2021: Augnito solutions launched in the UK
  • 2023: third consecutive NHS Commercial Solutions Framework appointment
  • 2024: joined AXREM
02

Technology developed with clinical purpose

Eight years of AI research, medical transcription knowledge and collaboration with engineers, analysts and clinicians led to Augnito. The aim remains practical: reduce administration while preserving accuracy and security.

03

Values that guide the team

Innovation is assessed by its ability to improve real workflows. Scribetech prioritises clinicians, continuous improvement and measurable commercial value for NHS Trusts and private healthcare.

  • Disruptive innovation
  • Putting clinicians first
  • Continuous improvement
  • Delivering commercial value

See how this fits your workflow.

Talk to Scribetech about your clinical, technical and organisational needs.

Contact our team